David Feigal

David Feigal

Director/Board Member at SPECTRAL MEDICAL INC.

Net worth: - $ as of 2024-04-29

74 year
Health Technology
Consumer Services
Commercial Services

Profile

David W.
Feigal
is currently the Director at Spectral Medical, Inc. since 2023 and the Principal at NDA Partners LLC since 2004.
He previously worked as the Director at Amarin Corp.
Plc in 2011, Director at Aspect Medical Systems, Inc. from 2004 to 2009, Non-Executive Director at Renovo Ltd., Chief Medical Officer at CytoDyn, Inc., SVP-Global Regulatory & Global Safety Surveillance at Elan Pharmaceuticals LLC, and Business Advisor at Aphelion Capital LLC.
Dr. Feigal holds a doctorate degree from Stanford University and a graduate degree from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-04 0 ( -.--% ) - $ 2024-04-29

David Feigal active positions

CompaniesPositionStart
SPECTRAL MEDICAL INC. Director/Board Member 2023-06-21
Corporate Officer/Principal 2004-04-30
All active positions of David Feigal

Former positions of David Feigal

CompaniesPositionEnd
AMARIN CORPORATION PLC Director/Board Member 2011-11-21
Corporate Officer/Principal 2009-11-04
Director/Board Member 2009-04-07
Director/Board Member 2007-07-22
CYTODYN INC. Chief Tech/Sci/R&D Officer -
See the detail of David Feigal's experience

Training of David Feigal

Stanford University Doctorate Degree
University of California, Berkeley Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Feigal's experience

Connections

25

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
AMARIN CORPORATION PLC

Health Technology

CYTODYN INC.

Health Technology

SPECTRAL MEDICAL INC.

Health Technology

Private companies5

Health Technology

Commercial Services

Health Technology

Finance

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW